Impact of 5-aminolevulinic acid with iron supplementation on exercise efficiency and home-based walking training achievement in older women
A reduction in exercise efficiency with aging limits daily living activities. We examined whether 5-aminolevulinic acid (ALA) with sodium ferrous citrate (SFC) increased exercise efficiency and voluntary achievement of interval walking training (IWT) in older women. Ten women [65 ± 3(SD) yr] who had...
Saved in:
| Published in | Journal of applied physiology (1985) Vol. 120; no. 1; pp. 87 - 96 |
|---|---|
| Main Authors | , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
American Physiological Society
01.01.2016
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 8750-7587 1522-1601 1522-1601 |
| DOI | 10.1152/japplphysiol.00582.2015 |
Cover
| Abstract | A reduction in exercise efficiency with aging limits daily living activities. We examined whether 5-aminolevulinic acid (ALA) with sodium ferrous citrate (SFC) increased exercise efficiency and voluntary achievement of interval walking training (IWT) in older women. Ten women [65 ± 3(SD) yr] who had performed IWT for >12 mo and were currently performing IWT participated in this study. The study was conducted in a placebo-controlled, double-blind crossover design. All subjects underwent two trials for 7 days each in which they performed IWT with ALA+SFC (100 and 115 mg/day, respectively) or placebo supplement intake (CNT), intermittently with a 2-wk washout period. Before and after each trial, subjects underwent a graded cycling test at 27.0°C atmospheric temperature and 50% relative humidity, and oxygen consumption rate, carbon dioxide production rate, and lactate concentration in plasma were measured. Furthermore, for the first 6 days of each trial, exercise intensity for IWT was measured by accelerometry. We found that, in the ALA+SFC trial, oxygen consumption rate and carbon dioxide production rate during graded cycling decreased by 12% ( P < 0.001) and 11% ( P = 0.001) at every workload, respectively, accompanied by a 16% reduction in lactate concentration in plasma ( P < 0.001), although all remained unchanged in the CNT trial ( P > 0.2). All of the reductions were significantly greater in the ALA+SFC than the CNT trial ( P < 0.05). Furthermore, the training days, impulse, and time at fast walking were 42% ( P = 0.028), 102% ( P = 0.027), and 69% ( P = 0.039) higher during the ALA+SFC than the CNT intake period, respectively. Thus ALA+SFC supplementation augmented exercise efficiency and thereby improved IWT achievement in older women. |
|---|---|
| AbstractList | A reduction in exercise efficiency with aging limits daily living activities. We examined whether 5-aminolevulinic acid (ALA) with sodium ferrous citrate (SFC) increased exercise efficiency and voluntary achievement of interval walking training (IWT) in older women. Ten women [65 +/- 3(SD) yr] who had performed IWT for >12 mo and were currently performing IWT participated in this study. The study was conducted in a placebo-controlled, double-blind crossover design. All subjects underwent two trials for 7 days each in which they performed IWT with ALA + SFC (100 and 115 mg/day, respectively) or placebo supplement intake (CNT), intermittently with a 2-wk washout period. Before and after each trial, subjects underwent a graded cycling test at 27.0 degrees C atmospheric temperature and 50% relative humidity, and oxygen consumption rate, carbon dioxide production rate, and lactate concentration in plasma were measured. Furthermore, for the first 6 days of each trial, exercise intensity for IWT was measured by accelerometry. We found that, in the ALA+SFC trial, oxygen consumption rate and carbon dioxide production rate during graded cycling decreased by 12% (P < 0.001) and 11% (P = 0.001) at every workload, respectively, accompanied by a 16% reduction in lactate concentration in plasma (P < 0.001), although all remained unchanged in the CNT trial (P > 0.2). All of the reductions were significantly greater in the ALA+SFC than the CNT trial (P < 0.05). Furthermore, the training days, impulse, and time at fast walking were 42% (P = 0.028), 102% (P = 0.027), and 69% (P = 0.039) higher during the ALA+SFC than the CNT intake period, respectively. Thus ALA+SFC supplementation augmented exercise efficiency and thereby improved IWT achievement in older women. A reduction in exercise efficiency with aging limits daily living activities. We examined whether 5-aminolevulinic acid (ALA) with sodium ferrous citrate (SFC) increased exercise efficiency and voluntary achievement of interval walking training (IWT) in older women. Ten women [65 ± 3(SD) yr] who had performed IWT for >12 mo and were currently performing IWT participated in this study. The study was conducted in a placebo-controlled, double-blind crossover design. All subjects underwent two trials for 7 days each in which they performed IWT with ALA+SFC (100 and 115 mg/day, respectively) or placebo supplement intake (CNT), intermittently with a 2-wk washout period. Before and after each trial, subjects underwent a graded cycling test at 27.0 °C atmospheric temperature and 50% relative humidity, and oxygen consumption rate, carbon dioxide production rate, and lactate concentration in plasma were measured. Furthermore, for the first 6 days of each trial, exercise intensity for IWT was measured by accelerometry. We found that, in the ALA+SFC trial, oxygen consumption rate and carbon dioxide production rate during graded cycling decreased by 12% (P < 0.001) and 11% (P = 0.001) at every workload, respectively, accompanied by a 16% reduction in lactate concentration in plasma (P < 0.001), although all remained unchanged in the CNT trial (P > 0.2). All of the reductions were significantly greater in the ALA+SFC than the CNT trial (P < 0.05). Furthermore, the training days, impulse, and time at fast walking were 42% (P = 0.028), 102% (P = 0.027), and 69% (P = 0.039) higher during the ALA+SFC than the CNT intake period, respectively. Thus ALA+SFC supplementation augmented exercise efficiency and thereby improved IWT achievement in older women.A reduction in exercise efficiency with aging limits daily living activities. We examined whether 5-aminolevulinic acid (ALA) with sodium ferrous citrate (SFC) increased exercise efficiency and voluntary achievement of interval walking training (IWT) in older women. Ten women [65 ± 3(SD) yr] who had performed IWT for >12 mo and were currently performing IWT participated in this study. The study was conducted in a placebo-controlled, double-blind crossover design. All subjects underwent two trials for 7 days each in which they performed IWT with ALA+SFC (100 and 115 mg/day, respectively) or placebo supplement intake (CNT), intermittently with a 2-wk washout period. Before and after each trial, subjects underwent a graded cycling test at 27.0 °C atmospheric temperature and 50% relative humidity, and oxygen consumption rate, carbon dioxide production rate, and lactate concentration in plasma were measured. Furthermore, for the first 6 days of each trial, exercise intensity for IWT was measured by accelerometry. We found that, in the ALA+SFC trial, oxygen consumption rate and carbon dioxide production rate during graded cycling decreased by 12% (P < 0.001) and 11% (P = 0.001) at every workload, respectively, accompanied by a 16% reduction in lactate concentration in plasma (P < 0.001), although all remained unchanged in the CNT trial (P > 0.2). All of the reductions were significantly greater in the ALA+SFC than the CNT trial (P < 0.05). Furthermore, the training days, impulse, and time at fast walking were 42% (P = 0.028), 102% (P = 0.027), and 69% (P = 0.039) higher during the ALA+SFC than the CNT intake period, respectively. Thus ALA+SFC supplementation augmented exercise efficiency and thereby improved IWT achievement in older women. A reduction in exercise efficiency with aging limits daily living activities. We examined whether 5-aminolevulinic acid (ALA) with sodium ferrous citrate (SFC) increased exercise efficiency and voluntary achievement of interval walking training (IWT) in older women. Ten women [65 ± 3(SD) yr] who had performed IWT for >12 mo and were currently performing IWT participated in this study. The study was conducted in a placebo-controlled, double-blind crossover design. All subjects underwent two trials for 7 days each in which they performed IWT with ALA+SFC (100 and 115 mg/day, respectively) or placebo supplement intake (CNT), intermittently with a 2-wk washout period. Before and after each trial, subjects underwent a graded cycling test at 27.0°C atmospheric temperature and 50% relative humidity, and oxygen consumption rate, carbon dioxide production rate, and lactate concentration in plasma were measured. Furthermore, for the first 6 days of each trial, exercise intensity for IWT was measured by accelerometry. We found that, in the ALA+SFC trial, oxygen consumption rate and carbon dioxide production rate during graded cycling decreased by 12% ( P < 0.001) and 11% ( P = 0.001) at every workload, respectively, accompanied by a 16% reduction in lactate concentration in plasma ( P < 0.001), although all remained unchanged in the CNT trial ( P > 0.2). All of the reductions were significantly greater in the ALA+SFC than the CNT trial ( P < 0.05). Furthermore, the training days, impulse, and time at fast walking were 42% ( P = 0.028), 102% ( P = 0.027), and 69% ( P = 0.039) higher during the ALA+SFC than the CNT intake period, respectively. Thus ALA+SFC supplementation augmented exercise efficiency and thereby improved IWT achievement in older women. A reduction in exercise efficiency with aging limits daily living activities. We examined whether 5-aminolevulinic acid (ALA) with sodium ferrous citrate (SFC) increased exercise efficiency and voluntary achievement of interval walking training (IWT) in older women. Ten women [65 ± 3(SD) yr] who had performed IWT for >12 mo and were currently performing IWT participated in this study. The study was conducted in a placebo-controlled, double-blind crossover design. All subjects underwent two trials for 7 days each in which they performed IWT with ALA+SFC (100 and 115 mg/day, respectively) or placebo supplement intake (CNT), intermittently with a 2-wk washout period. Before and after each trial, subjects underwent a graded cycling test at 27.0°C atmospheric temperature and 50% relative humidity, and oxygen consumption rate, carbon dioxide production rate, and lactate concentration in plasma were measured. Furthermore, for the first 6 days of each trial, exercise intensity for IWT was measured by accelerometry. We found that, in the ALA+SFC trial, oxygen consumption rate and carbon dioxide production rate during graded cycling decreased by 12% ( P < 0.001) and 11% ( P = 0.001) at every workload, respectively, accompanied by a 16% reduction in lactate concentration in plasma ( P < 0.001), although all remained unchanged in the CNT trial ( P > 0.2). All of the reductions were significantly greater in the ALA+SFC than the CNT trial ( P < 0.05). Furthermore, the training days, impulse, and time at fast walking were 42% ( P = 0.028), 102% ( P = 0.027), and 69% ( P = 0.039) higher during the ALA+SFC than the CNT intake period, respectively. Thus ALA+SFC supplementation augmented exercise efficiency and thereby improved IWT achievement in older women. A reduction in exercise efficiency with aging limits daily living activities. We examined whether 5-aminolevulinic acid (ALA) with sodium ferrous citrate (SFC) increased exercise efficiency and voluntary achievement of interval walking training (IWT) in older women. Ten women [65 ± 3(SD) yr] who had performed IWT for >12 mo and were currently performing IWT participated in this study. The study was conducted in a placebo-controlled, double-blind crossover design. All subjects underwent two trials for 7 days each in which they performed IWT with ALA+SFC (100 and 115 mg/day, respectively) or placebo supplement intake (CNT), intermittently with a 2-wk washout period. Before and after each trial, subjects underwent a graded cycling test at 27.0 °C atmospheric temperature and 50% relative humidity, and oxygen consumption rate, carbon dioxide production rate, and lactate concentration in plasma were measured. Furthermore, for the first 6 days of each trial, exercise intensity for IWT was measured by accelerometry. We found that, in the ALA+SFC trial, oxygen consumption rate and carbon dioxide production rate during graded cycling decreased by 12% (P < 0.001) and 11% (P = 0.001) at every workload, respectively, accompanied by a 16% reduction in lactate concentration in plasma (P < 0.001), although all remained unchanged in the CNT trial (P > 0.2). All of the reductions were significantly greater in the ALA+SFC than the CNT trial (P < 0.05). Furthermore, the training days, impulse, and time at fast walking were 42% (P = 0.028), 102% (P = 0.027), and 69% (P = 0.039) higher during the ALA+SFC than the CNT intake period, respectively. Thus ALA+SFC supplementation augmented exercise efficiency and thereby improved IWT achievement in older women. A reduction in exercise efficiency with aging limits daily living activities. We examined whether 5-aminolevulinic acid (ALA) with sodium ferrous citrate (SFC) increased exercise efficiency and voluntary achievement of interval walking training (IWT) in older women. Ten women [65 plus or minus 3(SD) yr] who had performed IWT for >12 mo and were currently performing IWT participated in this study. The study was conducted in a placebo-controlled, double-blind crossover design. All subjects underwent two trials for 7 days each in which they performed IWT with ALA+SFC (100 and 115 mg/day, respectively) or placebo supplement intake (CNT), intermittently with a 2-wk washout period. Before and after each trial, subjects underwent a graded cycling test at 27.0 degree C atmospheric temperature and 50% relative humidity, and oxygen consumption rate, carbon dioxide production rate, and lactate concentration in plasma were measured. Furthermore, for the first 6 days of each trial, exercise intensity for IWT was measured by accelerometry. We found that, in the ALA+SFC trial, oxygen consumption rate and carbon dioxide production rate during graded cycling decreased by 12% (P < 0.001) and 11% (P = 0.001) at every workload, respectively, accompanied by a 16% reduction in lactate concentration in plasma (P < 0.001), although all remained unchanged in the CNT trial (P > 0.2). All of the reductions were significantly greater in the ALA+SFC than the CNT trial (P < 0.05). Furthermore, the training days, impulse, and time at fast walking were 42% (P = 0.028), 102% (P = 0.027), and 69% (P = 0.039) higher during the ALA+SFC than the CNT intake period, respectively. Thus ALA+SFC supplementation augmented exercise efficiency and thereby improved IWT achievement in older women. |
| Author | Kataoka, Yufuko Ikegawa, Shigeki Masuki, Shizue Kamijo, Yoshi-ichiro Tanaka, Tohru Nose, Hiroshi Takahashi, Kiwamu Morita, Atsumi Nakajima, Motowo Ogawa, Yu Sumiyoshi, Eri |
| Author_xml | – sequence: 1 givenname: Shizue surname: Masuki fullname: Masuki, Shizue organization: Department of Sports Medical Sciences, Shinshu University Graduate School of Medicine, Matsumoto, Japan;, Institute for Biomedical Sciences, Shinshu University, Matsumoto, Japan; and – sequence: 2 givenname: Atsumi surname: Morita fullname: Morita, Atsumi organization: Department of Sports Medical Sciences, Shinshu University Graduate School of Medicine, Matsumoto, Japan – sequence: 3 givenname: Yoshi-ichiro surname: Kamijo fullname: Kamijo, Yoshi-ichiro organization: Department of Sports Medical Sciences, Shinshu University Graduate School of Medicine, Matsumoto, Japan;, Institute for Biomedical Sciences, Shinshu University, Matsumoto, Japan; and – sequence: 4 givenname: Shigeki surname: Ikegawa fullname: Ikegawa, Shigeki organization: Department of Sports Medical Sciences, Shinshu University Graduate School of Medicine, Matsumoto, Japan – sequence: 5 givenname: Yufuko surname: Kataoka fullname: Kataoka, Yufuko organization: Department of Sports Medical Sciences, Shinshu University Graduate School of Medicine, Matsumoto, Japan – sequence: 6 givenname: Yu surname: Ogawa fullname: Ogawa, Yu organization: Department of Sports Medical Sciences, Shinshu University Graduate School of Medicine, Matsumoto, Japan – sequence: 7 givenname: Eri surname: Sumiyoshi fullname: Sumiyoshi, Eri organization: Department of Sports Medical Sciences, Shinshu University Graduate School of Medicine, Matsumoto, Japan – sequence: 8 givenname: Kiwamu surname: Takahashi fullname: Takahashi, Kiwamu organization: Department of R&D, SBI Pharmaceuticals Co., Ltd., Tokyo, Japan – sequence: 9 givenname: Tohru surname: Tanaka fullname: Tanaka, Tohru organization: Department of R&D, SBI Pharmaceuticals Co., Ltd., Tokyo, Japan – sequence: 10 givenname: Motowo surname: Nakajima fullname: Nakajima, Motowo organization: Department of R&D, SBI Pharmaceuticals Co., Ltd., Tokyo, Japan – sequence: 11 givenname: Hiroshi surname: Nose fullname: Nose, Hiroshi organization: Department of Sports Medical Sciences, Shinshu University Graduate School of Medicine, Matsumoto, Japan;, Institute for Biomedical Sciences, Shinshu University, Matsumoto, Japan; and |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26514619$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkt9uFCEUxolpY7fVV1ASb7yZFWZgBi40MY1_mjTpjV4TFs50WRkYYWbrPoMvLdutTe1NTUiA8Ps-OJzvFB2FGACh15QsKeX1u40eRz-ud9lFvySEi3pZE8qfoUU5rSvaEnqEFqLjpOq46E7Qac4bQihjnD5HJ3XLKWupXKDfF8OozYRjj3mlBxeih-3sXXAGa-MsvnHTGrsUA85zuRMGCJOeXNmXAb8gGZcBQ9874yCYHdbB4nUcoFrpDEWv_Q8XrvGUdDEtC23WDra3PtgVF28h4ZsiCC_Qca99hpd38xn6_vnTt_Ov1eXVl4vzj5eV4ZROlaSs19JIYa1mnQBDV71oNWFctp2VlpmGmd5KqXtmG9ZYDbWAuhFcl5Jb0pyhDwffcV4NYE15SdJejckNOu1U1E79exLcWl3HrWKtFIzRYvD2ziDFnzPkSQ0uG_BeB4hzVlQS1nXlavk02gnCadNx9h8obwiRRDQFffMI3cQ5hfJpe6qtS385L9Srh3XeF_i3-wXoDoBJMecE_T1CidrnTD3MmbrNmdrnrCjfP1Iad4jFvs_-Sf0frMPhnQ |
| CitedBy_id | crossref_primary_10_1016_j_isci_2024_111477 crossref_primary_10_1249_JES_0000000000000113 crossref_primary_10_3390_nu15132866 crossref_primary_10_2174_2666958702101010052 crossref_primary_10_3143_geriatrics_54_10 crossref_primary_10_1016_j_conctc_2020_100593 crossref_primary_10_3389_fbioe_2022_841443 crossref_primary_10_1038_s41598_018_25452_2 crossref_primary_10_14814_phy2_14887 crossref_primary_10_15583_jpchrom_2022_017 crossref_primary_10_3892_etm_2021_10889 crossref_primary_10_3390_ijms25020988 crossref_primary_10_1016_j_exger_2021_111356 crossref_primary_10_1007_s00484_020_01865_5 crossref_primary_10_1038_s41598_017_03917_0 crossref_primary_10_1038_s41598_020_72763_4 |
| Cites_doi | 10.1016/S0140-6736(89)92143-0 10.1249/MSS.0000000000000398 10.1038/nature07206 10.1249/01.MSS.0000089350.54959.CB 10.1136/bjsm.2009.064816 10.1016/j.intimp.2014.02.003 10.1152/jappl.1986.60.6.2020 10.1113/jphysiol.2009.179499 10.1152/japplphysiol.00819.2014 10.1111/j.1600-0838.2006.00520.x 10.1186/1756-0500-4-66 10.1152/japplphysiol.91654.2008 10.1016/j.bbrc.2010.09.009 10.1152/jappl.1975.38.6.1132 10.1152/jappl.1990.68.1.329 10.1016/j.nut.2013.02.008 10.1001/jama.290.13.1757 10.1111/j.1365-4632.2008.03783.x 10.1016/j.pain.2004.03.043 10.31989/ffhd.v4i9.151 10.1152/jappl.2001.90.3.1137 10.1093/gerona/gls196 10.1111/j.1752-8062.2012.00421.x 10.1016/0022-510X(90)90006-9 10.1111/j.1469-7793.1999.0921p.x 10.1249/MSS.0b013e3181e05526 10.1152/ajpregu.00875.2007 10.4065/82.7.803 10.1113/eph8602209 10.1073/pnas.93.26.15364 10.1016/0891-5849(93)90139-L 10.1249/MSS.0b013e3181a9c452 10.1152/japplphysiol.01355.2009 10.1152/ajplung.00482.2005 10.1073/pnas.0501559102 10.1042/BJ20042130 10.1016/0304-3940(90)90437-E 10.1007/978-1-4615-4711-2_17 10.1113/expphysiol.2012.067314 10.1152/jappl.2000.89.6.2196 |
| ContentType | Journal Article |
| Copyright | Copyright © 2016 the American Physiological Society. Copyright American Physiological Society Jan 1, 2016 Copyright © 2016 the American Physiological Society 2016 American Physiological Society |
| Copyright_xml | – notice: Copyright © 2016 the American Physiological Society. – notice: Copyright American Physiological Society Jan 1, 2016 – notice: Copyright © 2016 the American Physiological Society 2016 American Physiological Society |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QP 7QR 7TK 7TS 7U7 8FD C1K FR3 P64 7X8 5PM |
| DOI | 10.1152/japplphysiol.00582.2015 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Neurosciences Abstracts Physical Education Index Toxicology Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Technology Research Database Toxicology Abstracts Chemoreception Abstracts Engineering Research Database Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Physical Education Index Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic CrossRef Technology Research Database MEDLINE Physical Education Index |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Anatomy & Physiology |
| EISSN | 1522-1601 |
| EndPage | 96 |
| ExternalDocumentID | PMC4698441 3919705811 26514619 10_1152_japplphysiol_00582_2015 |
| Genre | Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article Feature |
| GrantInformation_xml | – fundername: Japan Society for the Promotion of Science (JSPS) grantid: 25670117 |
| GroupedDBID | --- -~X .55 18M 29J 2WC 4.4 53G 5VS 85S AAFWJ AAYXX ABCQX ABDNZ ABHWK ABJNI ABKWE ABOCM ACBEA ACGFO ACGFS ACIWK ACPRK ADBBV ADFNX AEILP AENEX AFOSN AFRAH ALMA_UNASSIGNED_HOLDINGS BAWUL BKKCC BTFSW CITATION CS3 DIK DU5 E3Z EBS EJD EMOBN F5P FRP GX1 H13 H~9 ITBOX KQ8 L7B OK1 P2P P6G PQQKQ RAP RHI RPL RPRKH SJN TR2 UHB UKR UPT W8F WH7 WOQ X7M XSW YBH YQT YWH ~02 CGR CUY CVF ECM EIF NPM 7QP 7QR 7TK 7TS 7U7 8FD C1K FR3 P64 7X8 5PM P-O |
| ID | FETCH-LOGICAL-c511t-914fa9c98dda478ec1bf86a045967d9d4c34cfd99af4d343dae28e2385a619603 |
| ISSN | 8750-7587 1522-1601 |
| IngestDate | Thu Aug 21 18:27:21 EDT 2025 Fri Sep 05 08:53:43 EDT 2025 Fri Sep 05 09:25:38 EDT 2025 Fri Sep 05 05:25:48 EDT 2025 Mon Jun 30 10:50:19 EDT 2025 Thu Apr 03 07:04:55 EDT 2025 Thu Apr 24 23:03:26 EDT 2025 Tue Jul 01 01:13:50 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | exercise efficiency respiratory response home-based walking training achievement 5-aminolevulinic acid |
| Language | English |
| License | Copyright © 2016 the American Physiological Society. Licensed under Creative Commons Attribution CC-BY 3.0: © the American Physiological Society. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c511t-914fa9c98dda478ec1bf86a045967d9d4c34cfd99af4d343dae28e2385a619603 |
| Notes | SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 S. Masuki and A. Morita contributed equally to this work. |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC4698441 |
| PMID | 26514619 |
| PQID | 1756226555 |
| PQPubID | 40905 |
| PageCount | 10 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4698441 proquest_miscellaneous_1904773439 proquest_miscellaneous_1780513754 proquest_miscellaneous_1753009083 proquest_journals_1756226555 pubmed_primary_26514619 crossref_primary_10_1152_japplphysiol_00582_2015 crossref_citationtrail_10_1152_japplphysiol_00582_2015 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2016-01-01 |
| PublicationDateYYYYMMDD | 2016-01-01 |
| PublicationDate_xml | – month: 01 year: 2016 text: 2016-01-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: Bethesda – name: Bethesda, MD |
| PublicationTitle | Journal of applied physiology (1985) |
| PublicationTitleAlternate | J Appl Physiol (1985) |
| PublicationYear | 2016 |
| Publisher | American Physiological Society |
| Publisher_xml | – name: American Physiological Society |
| References | B20 American College of Sports Medicine (B1) 2010 B21 B22 B23 B24 B25 Åstrand PO (B2) 1986 B26 B27 Reiter RJ (B41) 1986; 21 B28 Ogura S (B37) 2011 Chow SC (B8) 1992 B30 B31 B32 B33 B34 B35 B36 Haskell WL (B19) 1998 B38 Yamashita N (B51) 2014; 4 B3 B4 Sacchetti M (B47) 2010; 42 B5 B7 Ministry of Health, Labor, and Welfare of Japan (B29) 2010 B9 B40 B42 B43 B45 B46 B48 B49 Fueki S (B15) 2010; 19 Ota U (B39) 2013; 1 B50 B52 B10 B11 B12 B13 B14 B16 B17 B18 Brooks GA (B6) 1996 |
| References_xml | – start-page: 152 volume-title: ACSM's Guidelines for Exercise Testing and Prescription year: 2010 ident: B1 – ident: B50 doi: 10.1016/S0140-6736(89)92143-0 – volume-title: [Dietary Reference Intakes for Japanese 2010] year: 2010 ident: B29 – ident: B17 doi: 10.1249/MSS.0000000000000398 – ident: B18 doi: 10.1038/nature07206 – ident: B7 – start-page: 399 volume-title: The 1997 Nagano Symposium on Sports Sciences year: 1998 ident: B19 – ident: B24 doi: 10.1249/01.MSS.0000089350.54959.CB – ident: B30 doi: 10.1136/bjsm.2009.064816 – ident: B35 doi: 10.1016/j.intimp.2014.02.003 – ident: B3 doi: 10.1152/jappl.1986.60.6.2020 – start-page: 3 volume-title: Aminolevulinic Acid year: 2011 ident: B37 – volume: 19 start-page: 9 year: 2010 ident: B15 publication-title: Porphyrins – ident: B36 doi: 10.1113/jphysiol.2009.179499 – ident: B27 doi: 10.1152/japplphysiol.00819.2014 – ident: B40 doi: 10.1111/j.1600-0838.2006.00520.x – ident: B38 doi: 10.1186/1756-0500-4-66 – ident: B5 doi: 10.1152/japplphysiol.91654.2008 – ident: B42 doi: 10.1016/j.bbrc.2010.09.009 – ident: B16 doi: 10.1152/jappl.1975.38.6.1132 – ident: B14 doi: 10.1152/jappl.1990.68.1.329 – ident: B21 doi: 10.1016/j.nut.2013.02.008 – ident: B26 doi: 10.1001/jama.290.13.1757 – start-page: 48 volume-title: Design and Analysis of Bioavailability and Bioequivalence Studies year: 1992 ident: B8 – ident: B31 doi: 10.1111/j.1365-4632.2008.03783.x – ident: B22 doi: 10.1016/j.pain.2004.03.043 – volume: 4 start-page: 415 year: 2014 ident: B51 publication-title: J Funct Foods Health Dis doi: 10.31989/ffhd.v4i9.151 – ident: B23 doi: 10.1152/jappl.2001.90.3.1137 – ident: B9 doi: 10.1093/gerona/gls196 – ident: B43 doi: 10.1111/j.1752-8062.2012.00421.x – ident: B32 doi: 10.1016/0022-510X(90)90006-9 – ident: B46 doi: 10.1111/j.1469-7793.1999.0921p.x – volume: 42 start-page: 2128 year: 2010 ident: B47 publication-title: Med Sci Sports Exerc doi: 10.1249/MSS.0b013e3181e05526 – ident: B11 doi: 10.1152/ajpregu.00875.2007 – ident: B34 doi: 10.4065/82.7.803 – ident: B4 doi: 10.1113/eph8602209 – ident: B45 doi: 10.1073/pnas.93.26.15364 – ident: B49 doi: 10.1016/0891-5849(93)90139-L – ident: B52 doi: 10.1249/MSS.0b013e3181a9c452 – volume-title: Textbook of Work Physiology: Physiological Bases of Exercise year: 1986 ident: B2 – volume: 1 start-page: 3 year: 2013 ident: B39 publication-title: ALA-Porphyrin Sci – ident: B33 doi: 10.1152/japplphysiol.01355.2009 – ident: B28 doi: 10.1152/ajplung.00482.2005 – ident: B48 doi: 10.1073/pnas.0501559102 – ident: B13 doi: 10.1042/BJ20042130 – start-page: 37 volume-title: Exercise Physiology: Human Bioenergetics and Its Applications year: 1996 ident: B6 – ident: B12 doi: 10.1016/0304-3940(90)90437-E – volume: 21 start-page: 35 year: 1986 ident: B41 publication-title: J Neural Transm Suppl – ident: B20 doi: 10.1007/978-1-4615-4711-2_17 – ident: B10 doi: 10.1113/expphysiol.2012.067314 – ident: B25 doi: 10.1152/jappl.2000.89.6.2196 |
| SSID | ssj0014451 |
| Score | 2.2603126 |
| Snippet | A reduction in exercise efficiency with aging limits daily living activities. We examined whether 5-aminolevulinic acid (ALA) with sodium ferrous citrate (SFC)... |
| SourceID | pubmedcentral proquest pubmed crossref |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 87 |
| SubjectTerms | Accelerometry Aged Amino acids Aminolevulinic Acid - pharmacology Atmospheric temperature Carbon dioxide Carbon Dioxide - metabolism Citric Acid Cross-Over Studies Diet Dietary Supplements Double-Blind Method Exercise Exercise - physiology Female Ferrous Compounds - therapeutic use Humans Lactic Acid - blood Middle Aged Older people Oxygen consumption Oxygen Consumption - drug effects Physical Conditioning, Human - physiology Relative humidity Training Walking Walking - physiology Womens health |
| Title | Impact of 5-aminolevulinic acid with iron supplementation on exercise efficiency and home-based walking training achievement in older women |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/26514619 https://www.proquest.com/docview/1756226555 https://www.proquest.com/docview/1753009083 https://www.proquest.com/docview/1780513754 https://www.proquest.com/docview/1904773439 https://pubmed.ncbi.nlm.nih.gov/PMC4698441 |
| Volume | 120 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwELfKkBAvCDZghYGMhHipMtLE-fc4oU0D1gGilcpT5DjOGtomaElA7CvwSfiW3DlumrbbGEhV1NpO6vh-9t3Z94eQl9znictEYuAhoAEScWJwnFeRKZjrR8xnDjo4D07d4xF7N3bGnc7vltVSVUb74uJSv5L_oSqUAV3RS_YfKNs8FArgO9AXrkBhuN6Ixm8bF0fH4PM0y2fye6VcHXtcpNquHP3YegUm76wNxWsRMWuSLaFJR6pmeB2KaZLPpYHMDe7ns2k7j0QPLS-lijCuMgvkmOK7DuJwhZDLtZCrNlDqcE8YGSrwndYWxIAXVZ09-_MkvaiW1rg57lyo1auEYU0b5gDv-lVt8X7Ji0lqpNCr87wB-VSe8R9cP-5MTtP2zka_vbOhF2NQlPuuLpKXlC1WcMvcgGrRYuabbMKxVHoCGAP9_vuYXxEd82rn0tXA3KcfwqPRyUk4PBwPb5Hblucpi4D3n5YHVhjnTYXm1d3TpoTw-_UVf7MqCG1oN-tGui2pZ3if3NOUpAc19h6Qjsy2yc5Bxst8_pO-oh8bum6TOwNtp7FDftXIpHlC15FJEZkUkUkRmXQNmRQ-C2TSJTIpIJMukUk1MukCmbSFTJrCUxCZVCHzIRkdHQ7fHBs67YchQPovgf2yhAci8OOYM8-Xoh8lvstB9whcLw5iJmxYXOIg4AmLbWbHXFq-BNHT4S7wE9N-RLayPJO7hHoiCtzITqyEC8ZM4UvG4tiUZhK5QSTiLnEXNAiFjomPHZ-FSjd2rLBNvFARL0TidYnZ3PitDgvz91v2FkQO9RpShCC8u6AAOQ5Uv2iqYYXHYzueybxSbWzQhEBXuq6ND9wV01lf0yYwmefBgAVd8rjGVtN36AKITH2o8VZQ1zTAKPSrNVk6UdHoMQUt6FRPbtD_p-Tucp7vka3yvJLPQKYvo-dqNv0B_o4Dzg |
| linkProvider | Colorado Alliance of Research Libraries |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impact+of+5-aminolevulinic+acid+with+iron+supplementation+on+exercise+efficiency+and+home-based+walking+training+achievement+in+older+women&rft.jtitle=Journal+of+applied+physiology+%281985%29&rft.au=Masuki%2C+Shizue&rft.au=Morita%2C+Atsumi&rft.au=Kamijo%2C+Yoshi-ichiro&rft.au=Ikegawa%2C+Shigeki&rft.date=2016-01-01&rft.issn=1522-1601&rft.eissn=1522-1601&rft.volume=120&rft.issue=1&rft.spage=87&rft_id=info:doi/10.1152%2Fjapplphysiol.00582.2015&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=8750-7587&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=8750-7587&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=8750-7587&client=summon |